Cargando…

Novel cancer‐specific epidermal growth factor receptor antibody obtained from the serum of esophageal cancer patients with long‐term survival

Although esophageal cancer has a poor prognosis after recurrence, some patients have shown long‐term survival despite recurrence. We hypothesized that induction of either antitumor Abs or antitumor‐specific CTLs could play a role in long‐term survival (5 years or longer) in patients with recurrence...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takagi‐Maeda, Sayaka, Yajima, Satoshi, Suzuki, Takashi, Usami, Katsuaki, Takahashi, Nobuaki, Niwa, Rinpei, Shimada, Hideaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	ORIGINAL ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207364/ https://www.ncbi.nlm.nih.gov/pubmed/35348270 http://dx.doi.org/10.1111/cas.15350

Ejemplares similares

Preoperative Low Serum Calcium Levels Predict Poor Prognosis for Patients with Esophageal Cancer
por: Shiratori, Fumiaki, et al.
Publicado: (2021)

High serum PD‐L1 level is a poor prognostic biomarker in surgically treated esophageal cancer
por: Ito, Masaaki, et al.
Publicado: (2019)

Does Preoperative Low HbA1c Predict Esophageal Cancer Outcomes?
por: Kochi, Ryosuke, et al.
Publicado: (2019)

Diagnostic impact of high serum midkine level in patients with gastric cancer
por: Ito, Masaaki, et al.
Publicado: (2019)

Improving effector functions of antibodies for cancer treatment: Enhancing ADCC and CDC
por: Natsume, Akito, et al.
Publicado: (2009)

Neck Dissection for Thoracic Esophageal Squamous Cell Carcinoma
por: Yajima, Satoshi, et al.
Publicado: (2012)

Association of Serum Anti-PCSK9 Antibody Levels with Favorable Postoperative Prognosis in Esophageal Cancer
por: Ito, Masaaki, et al.
Publicado: (2021)

Is High Score of Preoperative Lactate Dehydrogenase to Albumin Ratio Predicting Poor Survivals in Esophageal Carcinoma Patients?
por: Shiratori, Fumiaki, et al.
Publicado: (2023)

Prognostic Impact of Pretreatment Serum CYFRA Status in 1047 Patients with Esophageal Squamous Cell Carcinoma Who Underwent Radical Resection: A Japan Esophageal Society Promotion Research
por: Ishioka, Nobuki, et al.
Publicado: (2021)

Randomized Phase II Study to Comparing Docetaxel/Nedaplatin versus Docetaxel for 5-Fluorouracil/Cisplatin Resistant Esophageal Squamous Cell Carcinoma
por: Yajima, Satoshi, et al.
Publicado: (2021)

Prevalence of serum galectin-1 autoantibodies in seven types of cancer: A potential biomarker
por: Nanami, Tatsuki, et al.
Publicado: (2021)

Is high serum programmed death ligand 1 level a risk factor for poor survival in patients with gastric cancer?
por: Ito, Masaaki, et al.
Publicado: (2018)

The combination of positive anti‑WDR1 antibodies with negative anti‑CFL1 antibodies in serum is a poor prognostic factor for patients with esophageal carcinoma
por: Ito, Masaaki, et al.
Publicado: (2023)

Serum WT1-271 IgM antibody as a novel diagnostic marker for Gastric Cancer
por: Ito, Masaaki, et al.
Publicado: (2022)

A Case of Dermatomyositis Along with Esophageal Cancer and Screening of Serum Transcriptional Intermediary Factor 1 Gamma Antibodies in Various Cancer Patients
por: Sumazaki, Makoto, et al.
Publicado: (2020)

A new technology for increasing therapeutic protein levels in the brain over extended periods
por: Nakano, Ryosuke, et al.
Publicado: (2019)

Comparison between a new assay system, Elecsys(®) Anti-p53, and conventional MESACUP™ for the detection of serum anti-p53 antibodies: A multi-institutional study
por: Suzuki, Takashi, et al.
Publicado: (2022)

A case of Barrett’s esophageal cancer with gastric mucosa-associated lymphoma
por: Shiratori, Fumiaki, et al.
Publicado: (2020)

Association between serum ligands and the skin toxicity of anti-epidermal growth factor receptor antibody in metastatic colorectal cancer
por: Takahashi, Naoki, et al.
Publicado: (2015)

Germline factor DDX4 functions in blood‐derived cancer cell phenotypes
por: Schudrowitz, Natalie, et al.
Publicado: (2017)

p53 molecular approach to diagnosis and treatment of esophageal squamous cell carcinoma
por: Shimada, Hideaki
Publicado: (2018)

Clinical Significance of Serum Chemokines in Esophageal Cancer
por: Li, Zhixiang, et al.
Publicado: (2019)

Clinical TNM staging for esophageal, gastric, and colorectal cancers in the era of neoadjuvant therapy: A systematic review of the literature
por: Shimada, Hideaki, et al.
Publicado: (2021)

Prognostic impact of p53 and/or NY‐ESO‐1 autoantibody induction in patients with gastroenterological cancers
por: Hoshino, Isamu, et al.
Publicado: (2020)

Phase 1 combination study of Eribulin mesylate with trastuzumab for advanced or recurrent human epidermal growth factor receptor 2 positive breast cancer
por: Mukai, Hirofumi, et al.
Publicado: (2014)

Cancer‐associated fibroblasts secrete Wnt2 to promote cancer progression in colorectal cancer
por: Aizawa, Takashi, et al.
Publicado: (2019)

Radiogenomics predicts the expression of microRNA-1246 in the serum of esophageal cancer patients
por: Hoshino, Isamu, et al.
Publicado: (2020)

Successful prevention of stenosis after circumferential endoscopic resection of esophageal cancer
por: Tanaka, Hitoshi, et al.
Publicado: (2023)

Evaluation of factors affecting epidermal growth factor receptor tyrosine kinase inhibitor-induced hepatotoxicity in Japanese patients with non-small cell lung cancer: a two-center retrospective study
por: Nagai, Hirofumi, et al.
Publicado: (2022)

Frequent Expression of Midkine Gene in Esophageal Cancer Suggests a Potential Usage of Its Promoter for Suicide Gene Therapy
por: Miyauchi, Motohiro, et al.
Publicado: (1999)

Panel of autoantibodies against multiple tumor‐associated antigens for detecting gastric cancer
por: Hoshino, Isamu, et al.
Publicado: (2017)

Efficacy of intraoperative recurrent laryngeal neuromonitoring during surgery for esophageal cancer
por: Takeda, Shigeru, et al.
Publicado: (2020)

Results Obtained with Protective Serum
Publicado: (1920)

Prognostic value of tumor-infiltrating lymphocytes in estrogen receptor-positive and human epidermal growth factor receptor 2-negative breast cancer
por: Honda, Chikako, et al.
Publicado: (2021)

Prognostic significance of serum inflammatory markers in esophageal cancer
por: Powell, Arfon G. M. T., et al.
Publicado: (2020)

The Distinctive Serum Metabolomes of Gastric, Esophageal and Colorectal Cancers
por: Ren, Zhenxing, et al.
Publicado: (2021)

Cytomegalovirus‐associated esophagitis on early esophageal cancer in immunocompetent host: a case report
por: Murakami, Daisuke, et al.
Publicado: (2021)

Serum midkine as a biomarker for malignancy, prognosis, and chemosensitivity in head and neck squamous cell carcinoma
por: Yamashita, Taku, et al.
Publicado: (2016)

Hyperbilirubinemia predicts the infectious complications after esophagectomy for esophageal cancer
por: Muneoka, Yusuke, et al.
Publicado: (2019)

Accuracy of the endoscopic evaluation of esophageal involvement in esophagogastric junction cancer
por: Sakai, Takeshi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8lbjs451t5oaq6dcf7r8a15vuj